Work

Abstract A107: Clinical trial combining proteasome (NPI-0052) and HDAC (vorinostat) inhibition in melanoma, pancreatic, and lung cancer

Year: 2009

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-09-a107

Authors: Michael Millward, Matthew A. Spear, Amanda Townsend, Christopher Sweeney, Shawgi Sukumaran, Angie Longenecker, Michael A. Palladino, G. Kenneth Lloyd, Saskia T.C Neuteboom, Timothy Price

Institutions: The University of Western Australia, Sir Charles Gairdner Hospital, Queen Elizabeth Hospital, Royal Adelaide Hospital

Language: English

Topic: Histone Deacetylase Inhibitors Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1996881061

Cites:

Cited by: 2

Related to: 10